Literature DB >> 11866

Cimetidine and ulcers.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 11866      PMCID： PMC1690017     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  8 in total

1.  Letter: H2-receptor antagonists for Z-E syndrome.

Authors:  J B Shumaker
Journal:  N Engl J Med       Date:  1976-04-29       Impact factor: 91.245

2.  Inhibition of food-stimulated gastric acid secretion by cimetidine.

Authors:  R E Pounder; J G Williams; R C Russell; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1976-03       Impact factor: 23.059

3.  Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.

Authors:  W L Burland; W A Duncan; T Hesselbo; J G Mills; P C Sharpe; S J Haggie; J H Wyllie
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

4.  Letter: Metiamide in Zollinger-Ellison syndrome.

Authors:  M H Thompson; C W Vanables; I T Miller; J D Reed; D J Sanders; E R Grund; E L Blair
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

5.  [Letter: Inhibitor of H 2 histamine receptors and the Zollinger-Ellison syndrome].

Authors:  S Bonfils; M Mignon; J P Accary
Journal:  Nouv Presse Med       Date:  1974-09-14

6.  Treatment of duodenal ulcer with cimetidine.

Authors:  S J Haggie; D C Fermont; J H Wyllie
Journal:  Lancet       Date:  1976-05-08       Impact factor: 79.321

7.  Cimetidine in the treatment of active duodenal and prepyloric ulcers.

Authors:  G Bodemar; A Walan
Journal:  Lancet       Date:  1976-07-24       Impact factor: 79.321

8.  Cimetidine in duodenal ulcer. Controlled trial.

Authors:  W S Blackwood; D P Maudgal; R G Pickard; D Lawrence; T C Northfield
Journal:  Lancet       Date:  1976-07-24       Impact factor: 79.321
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.